Reginald C Rampaul, MD
Obstetrics/Gynecology · Stockton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Rampaul’s office at (209) 476-2000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A80067 · Current
Licensed to practise in California · since 2002 · expires 2028-07-31 · University of Virginia School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$2,192 in 2024
Medicaid paid $2,192 for 260 billed services this clinician did in 2024, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 74 | $2,192 |
| TOBACCO NON-USER | 186 | $0 |
| 2024 | 260 | 2 | 25 | $2,192 |
| 2023 | 182 | 3 | 23 | $3,603 |
| 2022 | 62 | 1 | 25 | $2,698 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 122 | $1,948 |
| Return visit (30+ min) | 30 | $1,655 |
| TOBACCO NON-USER | 30 | $0 |
2022
| Short return visit (20+ min) | 62 | $2,698 |
Drugs they prescribed that Part D paid
$38,529
Pharmacies billed $38,529 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 470) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
395 generic and 75 brand-name prescriptions · $38,529 in drug cost · 36 antibiotic prescriptions to 24 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estring | 33 | $20,170 | $611 |
| Estradiol | 196 | $8,433 | $43 |
| Yuvafem | 17 | $1,916 | $113 |
| Vandazole | 27 | $1,556 | $58 |
| Climara | 11 | $1,539 | $140 |
See all 9 drugs
| Estring | 33 | $20,170 | $611 |
| Estradiol | 196 | $8,433 | $43 |
| Yuvafem | 17 | $1,916 | $113 |
| Vandazole | 27 | $1,556 | $58 |
| Climara | 11 | $1,539 | $140 |
| Clobetasol Propionate | 32 | $660 | $21 |
| Trospium Chloride | 12 | $541 | $45 |
| Medroxyprogesterone Acetate | 11 | $143 | $13 |
| Fluconazole | 17 | $104 | $6 |
Year by year
| 2024 | 470 | 203 | 0% (0) | 16% | $38,529 |
| 2023 | 452 | 201 | 0% (0) | 16% | $42,970 |
| 2022 | 196 | 107 | 0% (0) | 12% | $18,487 |
| 2021 | 158 | 81 | 0% (0) | 7% | $9,976 |
| 2020 | 124 | 55 | 0% (0) | 10% | $8,383 |
| 2019 | 113 | 66 | 0% (0) | None | $7,400 |
| 2018 | 142 | 66 | None | 10% | $11,999 |
| 2017 | 179 | 70 | 0% (0) | 13% | $27,068 |
| 2016 | 172 | 78 | 0% (0) | 14% | $23,102 |
| 2015 | 193 | 82 | None | 16% | $23,850 |
| 2014 | 193 | 81 | None | 14% | $17,762 |
| 2013 | 206 | 81 | None | 19% | $14,476 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Estring | 49 | $29,016 | $592 |
| Estradiol | 158 | $7,115 | $45 |
| Yuvafem | 14 | $1,503 | $107 |
| Clobetasol Propionate | 31 | $712 | $23 |
| Vandazole | 20 | $505 | $25 |
| Acyclovir | 14 | $252 | $18 |
| Cephalexin | 16 | $164 | $10 |
| Fluconazole | 22 | $137 | $6 |
| Sulfamethoxazole-Trimethoprim | 16 | $95 | $6 |
2022: 3 drugs
| Estring | 21 | $11,906 | $567 |
| Estradiol | 95 | $4,140 | $44 |
| Fluconazole | 17 | $107 | $6 |
2021: 3 drugs
| Estradiol | 77 | $3,221 | $42 |
| Betamethasone Diprop Augmented | 13 | $842 | $65 |
| Fluconazole | 15 | $96 | $6 |
2020: 1 drug
| Estradiol | 65 | $2,711 | $42 |
2019: 2 drugs
| Estrace | 12 | $2,893 | $241 |
| Estradiol | 59 | $2,675 | $45 |
2018: 2 drugs
| Estrace | 61 | $7,931 | $130 |
| Estradiol | 16 | $396 | $25 |
2017: 4 drugs
| Estrace | 61 | $19,108 | $313 |
| Estradiol | 19 | $518 | $27 |
| Alendronate | 15 | $213 | $14 |
| Fluconazole | 19 | $124 | $7 |
2016: 3 drugs
| Estrace | 51 | $14,575 | $286 |
| Estradiol | 20 | $603 | $30 |
| Alendronate | 12 | $179 | $15 |
2015: 5 drugs
| Estrace | 64 | $15,305 | $239 |
| Premarin | 13 | $3,492 | $269 |
| Estradiol | 18 | $539 | $30 |
| Acyclovir | 14 | $269 | $19 |
| Fluconazole | 19 | $168 | $9 |
2014: 5 drugs
| Estrace | 58 | $12,032 | $207 |
| Estradiol | 30 | $609 | $20 |
| Acyclovir | 12 | $306 | $26 |
| Alendronate | 13 | $194 | $15 |
| Fluconazole | 19 | $166 | $9 |
2013: 7 drugs
| Estrace | 38 | $7,141 | $188 |
| Premarin | 16 | $2,364 | $148 |
| Estradiol | 40 | $810 | $20 |
| Nystatin-Triamcinolone | 13 | $772 | $59 |
| Alendronate | 16 | $238 | $15 |
| Acyclovir | 13 | $187 | $14 |
| Fluconazole | 20 | $114 | $6 |
Professional record
- NPI
- 1609955731
- Licence
- CA A80067California A80067: Current · expires 2028-07-31
- Trained
- University of Virginia School of Medicine, 1998
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A800670
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2006-11-02
- NPI last updated
- 2021-12-13
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.